AAAAAA

   
Results: 1-9 |
Results: 9
AN EXPLORATORY TRIAL OF 2 DOSAGES OF A NOVEL SYNTHETIC THROMBIN INHIBITOR (NAPSAGATRAN, RO 46-6240) COMPARED WITH UNFRACTIONATED HEPARIN FOR TREATMENT OF PROXIMAL DEEP-VEIN THROMBOSIS - RESULTS OF THE EUROPEANMULTICENTER ADVENT TRIAL
Authors: BOUNAMEAUX H EHRINGER H HULTING J RASCHE H RAPOLD HJ ZULTAK M RAMES A BASLE CH TENCATE JW SCHNEIDER PA GENEVA CH SCHMITT HE SLOSMAN DO PERRIER A SPANNAGL H GSCHWANDTNER ME BANYAI M KOPPENSTEINER R MINAR E STUMPFLEN A HAUMER M VERHAEGHE R VERMYLEN J WAUTRECHT JC TAGHIZADEH K BRUHN HD LINS M ZURBORN KH SCHWARZENBERG H SCHAUER J SCHEEL H RUHLMANN C VOIGT H WAGNER T SIEMENS HJ SCHWIEDER G HEENE D DEMPFLE CE HARENBERG J PFITZNER S BROCKHAUS W SCHUSTER O WEISSHAAR K SEBIGER R HOFMANN B ANDERS O KRAMMER B PLATH F LESTIN H BAUMANN N EHRERTREICH U MULLERESCH G RUPRECHT B WEDEEN G LARFARS G WALLVIK J BJUHR O DIDIER D DESMARAIS S WUTSCHERT R DEMOERLOOSE P CHRISTEN Y BERNARD C KUPKA S KIRISITS A JANSSEN M VERWEIJ G KRAAJ CJ SITTNER WD HANKA U MAIER A JOHANSSON AS JOHANSSON E OLESEN M BREIER E WITTKE B GOGGIN T STEPHENSON C TURKISH M WILLIAMS L DUTREIX C GAUTSCH A NONN D WARD R LOWE P LAD K GREEN D GRAVEL A
Citation: H. Bounameaux et al., AN EXPLORATORY TRIAL OF 2 DOSAGES OF A NOVEL SYNTHETIC THROMBIN INHIBITOR (NAPSAGATRAN, RO 46-6240) COMPARED WITH UNFRACTIONATED HEPARIN FOR TREATMENT OF PROXIMAL DEEP-VEIN THROMBOSIS - RESULTS OF THE EUROPEANMULTICENTER ADVENT TRIAL, Thrombosis and haemostasis, 78(3), 1997, pp. 997-1002
PATTERNS OF MYCOBACTERIUM-AVIUM CULTURE AND PCR POSITIVITY IN IMMUNODEFICIENT HIV-INFECTED PATIENTS - PROGRESSION FROM LOCALIZED TO SYSTEMIC-DISEASE
Authors: BOGNER JR RUSCHGERDES S MERTENSKOTTER T LOCH O EMMINGER C BAUMGARTEN R BROCKMEYER NH BROCKHAUS W JABLONOWSKI H STOEHR A ROTH A ALBRECHT H ROTH K TSCHAUDER S DIETRICH M
Citation: Jr. Bogner et al., PATTERNS OF MYCOBACTERIUM-AVIUM CULTURE AND PCR POSITIVITY IN IMMUNODEFICIENT HIV-INFECTED PATIENTS - PROGRESSION FROM LOCALIZED TO SYSTEMIC-DISEASE, Scandinavian journal of infectious diseases, 29(6), 1997, pp. 579-584
THE VENOUS THROMBOTIC RISK IN NONSURGICAL PATIENTS - EPIDEMIOLOGIC DATA AND EFFICACY SAFETY PROFILE OF A LOW-MOLECULAR-WEIGHT HEPARIN (ENOXAPARIN)
Authors: LECHLER E SCHRAMM W FLOSBACH CW BERGEMANN W BROCKHAUS W EGBRING R GARBOR M GEIDEL H HENGSTMANN JH JAGER K KELLER F LENZ K LUDWIG M MAURIN NJA NIESSNER H PICKLPFEFFER S PLATT D SCHAUER J SCHENTKE KU SCHULZ J SLANY J TEUFEL J HALBRITTER R THIELE G THIER WH TREESE N WAGNER T
Citation: E. Lechler et al., THE VENOUS THROMBOTIC RISK IN NONSURGICAL PATIENTS - EPIDEMIOLOGIC DATA AND EFFICACY SAFETY PROFILE OF A LOW-MOLECULAR-WEIGHT HEPARIN (ENOXAPARIN), Haemostasis, 26, 1996, pp. 49-56
A DOSE COMPARISON STUDY OF DIDANOSINE IN PATIENTS WITH VERY ADVANCED HIV-INFECTION WHO ARE INTOLERANT TO OR CLINICALLY DETERIORATE ON ZIDOVUDINE
Authors: JABLONOWSKI H ARASTEH K STASZEWSKI S RUF B STELLBRINK HJ SCHRAPPE M STOEHR A HAASE W SCHOMAKER U ROTHE BV THOMIS J STILLE W LAGE M POHLE HD ALBRECHT H FATKENHEUER G DIEHL V PLETTENBERG A SCHUSTER D KNECHTEN H RUHNKE M ALEXANDER M SCHWANDER S DIETRICH M RUBBERT A KALDEN JR EMMINGER C EICHENLAUB D SCHEDEL I DEICHER H HEHLMANN R RASOKAT H DENGLER HJ HOFFKEN G BROCKHAUS W ZIDEK W WILKE G FISCHER JT ULMER A PETZOLDT D PEES HW ZANGERLE R DUNCKER D KRIPPNER H RIEGER T KERN P
Citation: H. Jablonowski et al., A DOSE COMPARISON STUDY OF DIDANOSINE IN PATIENTS WITH VERY ADVANCED HIV-INFECTION WHO ARE INTOLERANT TO OR CLINICALLY DETERIORATE ON ZIDOVUDINE, AIDS, 9(5), 1995, pp. 463-469
AGGRESSIVE CHEMOTHERAPY WITH IDARUBICIN, ARA-C, VP-16, AMSACRIN, FOLLOWED BY G-CSF AND MAINTENANCE IMMUNOTHERAPY WITH INTERLEUKIN-2 FOR ADVANCED MYELODYSPLASTIC SYNDROMES AND HIGH-RISK ANLL
Authors: GANSER A HEIL G HOFMANN WK OTTMANN OG SEIPELT G FISCHER JT LANGER W BROCKHAUS W ITTEL TH BRACK N KNUTH A HOFFKEN K KLAUSMANN M FUHR HG BERGMANN L HOELZER D
Citation: A. Ganser et al., AGGRESSIVE CHEMOTHERAPY WITH IDARUBICIN, ARA-C, VP-16, AMSACRIN, FOLLOWED BY G-CSF AND MAINTENANCE IMMUNOTHERAPY WITH INTERLEUKIN-2 FOR ADVANCED MYELODYSPLASTIC SYNDROMES AND HIGH-RISK ANLL, Blood, 86(10), 1995, pp. 1722-1722
RANDOMIZED COMPARISON OF INTERFERON-ALPHA WITH BUSULFAN AND HYDROXYUREA IN CHRONIC MYELOGENOUS LEUKEMIA
Authors: HEHLMANN R HEIMPEL H HASFORD J KOLB HJ PRALLE H HOSSFELD DK QUEISSER W LOFFLER H HOCHHAUS A HEINZE B GEORGII A BARTRAM CR GRIESSHAMMER M BERGMANN L ESSERS U FALGE C QUEISSER U MEYER P SCHMITZ N EIMERMACHER H WALTHER F FETT W KLEEBERG UR KABISCH A NERL C ZIMMERMANN R MEURET G TICHELLI A KANZ L TIGGES FJ SCHMID L BROCKHAUS W TOBLER A REITER A PERKER M EMMERICH B VERPOORT K ZANKOVICH R VONWUSSOW P PRUMMER O THIELE J BUHR T CARBONELL F ANSARI H
Citation: R. Hehlmann et al., RANDOMIZED COMPARISON OF INTERFERON-ALPHA WITH BUSULFAN AND HYDROXYUREA IN CHRONIC MYELOGENOUS LEUKEMIA, Blood, 84(12), 1994, pp. 4064-4077
TREATMENT OF PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE FONTAINE STAGE-IV WITH INTRAVENOUS ILOPROST AND PGE(1) - A RANDOMIZED OPENCONTROLLED-STUDY
Authors: ALTSTAEDT HO BERZEWSKI B BREDDIN HK BROCKHAUS W BRUHN HD CACHOVAN M DIEHM C DORRLER J FRANKE CS DIETER J HACH W HELD K HEPP D HEY D HORSCH A HORSCH S MEINHOVEL K MORL H MULLERWIEFEL H SCHNITKER J SCHULTE KL SEIPEL L SIGEL H TASCHKE C TREESE N TRUBESTEIN G
Citation: Ho. Altstaedt et al., TREATMENT OF PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE FONTAINE STAGE-IV WITH INTRAVENOUS ILOPROST AND PGE(1) - A RANDOMIZED OPENCONTROLLED-STUDY, Prostaglandins, leukotrienes and essential fatty acids, 49(6), 1993, pp. 973-973
RANDOMIZED COMPARISON OF BUSULFAN AND HYDROXYUREA IN CHRONIC MYELOGENOUS LEUKEMIA - PROLONGATION OF SURVIVAL BY HYDROXYUREA
Authors: HEHLMANN R HEIMPEL H HASFORD J KOLB HJ PRALLE H HOSSFELD DK QUEISSER W LOFFLER H HEINZE B GEORGII A VONWUSSOW P BARTRAM C GRIESSHAMMER M BERGMANN L ESSERS U FALGE C HOCHHAUS A QUEISSER U SICK C MEYER P SCHMITZ N VERPOORT K EIMERMACHER H WALTHER F WESTERHAUSEN M KLEEBERG UR HEILEIN A KABISCH A BARZ C ZIMMERMANN R MEURET G TICHELLI A BERDEL WE KANZ L ANGER B TIGGES FJ SCHMID L BROCKHAUS W ZANKOVICH R SCHLAFER U WEISSENFELS I MAINZER K TOBLER A PERKER M HOHNLOSER J MESSENER D THIELE J BUHR T ANSARI H
Citation: R. Hehlmann et al., RANDOMIZED COMPARISON OF BUSULFAN AND HYDROXYUREA IN CHRONIC MYELOGENOUS LEUKEMIA - PROLONGATION OF SURVIVAL BY HYDROXYUREA, Blood, 82(2), 1993, pp. 398-407
AGGRESSIVE INDUCTION CHEMOTHERAPY WITH IDARUBICIN, ARA-C, VP-16, FOLLOWED BY G-CSF AND MAINTENANCE IMMUNOTHERAPY WITH INTERLEUKIN-2 FOR HIGH-RISK ANLL
Authors: GANSER A HEIL G SEIPELT G FISCHER JT LANGER G BROCKHAUS W ITTEL TH FUHR HG BERGMANN L HOELZER D
Citation: A. Ganser et al., AGGRESSIVE INDUCTION CHEMOTHERAPY WITH IDARUBICIN, ARA-C, VP-16, FOLLOWED BY G-CSF AND MAINTENANCE IMMUNOTHERAPY WITH INTERLEUKIN-2 FOR HIGH-RISK ANLL, Blood, 82(10), 1993, pp. 10000128-10000128
Risultati: 1-9 |